(Press-News.org) Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among them is the FAITAVI randomised clinical trial (RCT).
Background
The optimal management of patients with intermediate coronary artery disease (CAD) and severe aortic stenosis (AS) who are candidates for TAVI remains unclear. Recent trials comparing percutaneous coronary intervention (PCI) with conservative management of CAD patients undergoing TAVI yielded conflicting results leaving the question of how to manage these patients open until now.
To determine whether fractional flow reserve (FFR)-guided management improves clinical outcomes compared with angiography-guided revascularisation in stable TAVI patients the Functional Assessment In TAVI (FAITAVI) trial1 enrolled 320 patients who were randomised 1:1 between FFR-guided PCI and angiography-guided PCI.
In the angio-guided arm all lesions ≥50% in a vessel >2.5 mm were treated while in the physiology-guided arm lesions with FFR ≤0.80 were treated and >0.85 were deferred. For all FFR values between 0.81 and 0.85, repeating the measurement after TAVI implantation was recommended as FFR can change due to improved hyperaemic coronary flow after TAVI
The primary endpoint was major adverse cardiac and cerebrovascular events (MACCE) at 12-months follow-up including all-cause death, myocardial infarction, ischaemia-driven target vessel revascularisation, disabling stroke or major bleeding.
Results
The mean age – 86 years – and low SYNTAX scores – a median of 7 – was similar between the two groups.
FFR-guided PCI was associated with a lower rate of MACCE at 12-month follow-up in patients with intermediate CAD undergoing TAVI.
The primary endpoint occurred in 14 (8.5%) in the FFR-guided PCI group and in 25 patients (16.0%) in the angiography-guided PCI group, a finding primarily driven by lower rates of any-cause death and ischaemia-driven target vessel revascularisation.
Key learnings
These findings are of particular interest when facing the clinical challenges of managing a bystander coronary lesion identified during diagnostic evaluation for a valve intervention especially as CAD is present in over 50% of patients undergoing TAVI.
The recent NOTION-3 study demonstrated in patients with CAD undergoing TAVI that PCI was associated with a lower risk of events (any cause death, MI or revascularisation) at 2 years when compared with conservative treatment. However, unlike the NOTION-3 study2, the FAITAVI trial focused on intermediate coronary lesions, while angiographically severe lesions (DS >90%) were excluded. Furthermore, the study compared angiography vs physiology guidance and did not include an arm for conservative treatment.
The FAITAVI trial hypothesised that the management of coronary lesions according to their functional significance could be beneficial in the decision-making process of TAVI candidates with concomitant, stable CAD. The risk of a MACCE was significantly lower in patients allocated to the physiology-guided PCI strategy, mainly driven by a lower risk of death from any cause and ischaemia-driven TVR, further highlighting the potential advantages of FFR-guided PCI in patients undergoing complex interventions, including TAVI.
Conclusions and PCR recommendations
In this first study comparing FFR-guided PCI with angiography-guided PCI in patients with intermediate CAD and severe symptomatic AS undergoing TAVI, FFR-guided PCI was associated with a lower rate of MACCE at 12 months of follow-up.
This trial provides data that can impact clinical decision-making when dealing with patients who are candidates for TAVI and who present with intermediate coronary stenosis. Future studies are needed to further understand the impact of functional guided revascularisation on TAVI patients and its potential advantages versus conservative treatment.
References
Ribichini F, Pesarini G, Fabris T, et al. A randomised multicentre study of angiography- versus physiology-guided percutaneous coronary intervention in patients with coronary artery disease undergoing TAVI: design and rationale of the FAITAVI trial. EuroIntervention. 2024;20:e504-e510. doi: 10.4244/EIJ-D-23-00679. PMID: 38629420
Lønborg J, Jabbari R, Sabbah M, et al. PCI in Patients Undergoing Transcatheter Aortic-Valve Implantation. N Engl J Med. 2024;391:2189-2200. doi: 10.1056/NEJMoa2401513. Epub 2024 Aug 31. PMID: 39216095.
NOTES TO EDITORS
Key information
Session: Hotline /Late-Breaking Trials: Major Late-Breaking Trials from EuroPCR 2025
Presentation: Angiography versus physiology-guided PCI in patients undergoing TAVI: the functional assessment in TAVI (FAITAVI) trial
Presenter: Flavio Luciano Ribichini
Palais des Congrès Porte Maillot – Paris, France
21 May 2025 / 11:15 - 12:15 / Theatre Bleu END
EuroPCR 2025 – The FAITAVI trial: angiography versus physiology-guided PCI in patients undergoing TAVI – 12-month follow-up data
2025-05-21
ELSE PRESS RELEASES FROM THIS DATE:
EuroPCR 2025 – One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
2025-05-21
Background
While dual antiplatelet therapy (DAPT) has long been the standard of care for the management of acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI), there is an increasing awareness of the need to find a more patient-centred approach that strikes a balance between the ischaemic protection DAPT offers and the risk of bleeding complications it can create.
The effect of DAPT in dosage and duration on cardiovascular events and bleeding after implantation of drug-coated stents (DCS) in ACS patients, ...
PREVENT equation accurately estimated 10-year CVD risk and those with calcium buildup
2025-05-21
Research Highlights:
The American Heart Association’s PREVENTTM risk calculator accurately identified participants who had calcium buildup in their heart arteries and those who had a higher future heart attack risk, in an analysis of about 7,000 adults in New York City referred for heart disease screening.
The PREVENT scores also predicted future heart attack risk.
Embargoed until 4 a.m. CT/5 a.m. ET Wednesday, May 21, 2025
DALLAS, May 21, 2025 — The PREVENTTM risk calculator helped to identify people with plaque buildup in the arteries of the heart, in addition to predicting their risk of a future heart attack, according ...
Nano-engineered thermoelectrics enable scalable, compressor-free cooling
2025-05-21
Researchers at the Johns Hopkins Applied Physics Laboratory (APL) in Laurel, Maryland, have developed a new, easily manufacturable solid-state thermoelectric refrigeration technology with nano-engineered materials that is twice as efficient as devices made with commercially available bulk thermoelectric materials. As global demand grows for more energy-efficient, reliable and compact cooling solutions, this advancement offers a scalable alternative to traditional compressor-based refrigeration.
In a paper published in ...
Researchers identify a dual origin of cells controlling puberty and reproduction
2025-05-21
Researchers at the Francis Crick Institute have shown that gonadotrophs, cells in the pituitary gland with a key role in puberty and reproduction, come from two different populations, with the majority produced after birth rather than in the embryo, as previously thought.
A better understanding of when these important cells develop could help researchers and clinicians understand and treat disorders that impact puberty and fertility.
In the pituitary, a small gland located in the middle of the head and connected to the brain, gonadotrophs ...
Major step for flat and adjustable optics
2025-05-21
By carefully placing nanostructures on a flat surface, researchers at Linköping University, Sweden, have significantly improved the performance of so-called optical metasurfaces in conductive plastics. This is a major step for controllable flat optics, with future applications such as video holograms, invisibility materials, and sensors, as well as in biomedical imaging. The study has been published in the journal Nature Communications.
To control light, curved lenses are used today, that are often made of glass that is either concave or convex, ...
Less frequent stroke monitoring is safe, effective, and frees up resources, study finds
2025-05-21
Halving the number of times vital signs and neurological function are checked in low-risk patients after treatment for acute ischaemic stroke does not compromise care or recovery, according to new findings presented at the 11th European Stroke Organisation Conference in Helsinki, Finland.
Results from the Optimal Post rTpa-Iv Monitoring in Ischaemic Stroke Trial (OPTIMISTmain)1, simultaneously published in The Lancet, also showed that this approach also had flow-on benefits for nursing workflow and intensive care resources. The trial was led by Professor Craig Anderson from The George Institute for Global Health and UNSW ...
Living tattoos for buildings
2025-05-21
External walls of buildings are normally lifeless and have no additional function. An international team of researchers and companies, in which Carole Planchette from the Institute of Fluid Mechanics and Heat Transfer is involved, wants to change this by adding microbial life to building façades. In the project “Archibiome tattoo for resistant, responsive, and resilient cities” (REMEDY), the consortium is working on integrating specifically composed communities of beneficial microorganisms into ...
Could strawberry tree extract prevent and treat gastrointestinal disorders?
2025-05-21
New research in rats indicates that a Mediterranean plant may be an effective treatment for ulcerative colitis, a type of inflammatory bowel disease. The findings are published in the Journal of the Science of Food and Agriculture.
Various antioxidant and anti-inflammatory medications are used to treat ulcerative colitis, but they can cause numerous side effects. To test the potential of the Arbutus unedo plant (often referred to as the strawberry tree) that is native to the Mediterranean region, investigators gave rats doses of an extract from the plant ...
Can engaging in social activities prolong life?
2025-05-21
A study in the Journal of the American Geriatrics Society indicates that social engagement may help older individuals live longer.
In the study of 2,268 U.S. individuals aged 60 years and older who completed the Psychosocial and Lifestyle Questionnaires and provided blood samples in 2016, there was a strong association between engaging in social activities and a low risk of 4-year mortality. High social engagement was associated with a 42% lower mortality risk than low engagement.
Specific activities, such as charity work, engaging with grandchildren, and participation in sports or social clubs, were particularly significant predictors of a reduced risk ...
Has marijuana legalization affected traditional drug prescriptions?
2025-05-21
Approval of recreational and medical cannabis laws in most U.S. states has allowed individuals to legally obtain cannabis to treat certain medical ailments that had typically been treated with prescription drugs. New research in Health Economics reveals the impact that cannabis laws have had on such traditional prescriptions.
After analyzing prescription drug claims reported by small and large group insurers from 2010–2019 for working-age individuals, investigators found significant reductions in prescription drug claims per enrollee ...